Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[ ¹⁸ F]FDG whole-body PET-MR including an integrated breast MR protocol for locoregional and distant staging in breast cancer patients-a feasibility study.

Autor: van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands. Thiemo.nijnatten@mumc.nl.; GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands. Thiemo.nijnatten@mumc.nl., de Mooij CM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.; Division of Internal Medicine, Department of Medical Oncology, Maastricht University Medical Center+, Maastricht, The Netherlands., Mitea C; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands., Houwers J; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands., de Boer M; GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.; Division of Internal Medicine, Department of Medical Oncology, Maastricht University Medical Center+, Maastricht, The Netherlands., Smidt ML; GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands., Mottaghy FM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.; Department of Nuclear Medicine, University Hospital, RWTH Aachen University, Aachen, Germany., Wildberger JE; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.

Publikováno v: Insights into imaging [Insights Imaging] 2024 Oct 09; Vol. 15 (1), pp. 243. Date of Electronic Publication: 2024 Oct 09.

Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis.

Autor: Ploumen RAW; Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands. r.ploumen@maastrichtuniversity.nl.; GROW - School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands. r.ploumen@maastrichtuniversity.nl., de Mooij CM; Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands.; GROW - School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands., Gommers S; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands., Keymeulen KBMI; Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands., Smidt ML; Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands.; GROW - School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., van Nijnatten TJA; GROW - School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Publikováno v: European radiology [Eur Radiol] 2023 Aug; Vol. 33 (8), pp. 5423-5435. Date of Electronic Publication: 2023 Apr 05.

Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer.

Autor: de Mooij CM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands., van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands., Goorts B; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands., Kooreman LFS; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.; Department of Pathology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands., Raymakers IWM; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands., van Meijl SPL; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands., de Boer M; Department of Medical Oncology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands., Keymeulen KBMI; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands., Wildberger JE; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands., Mottaghy FM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; Department of Nuclear Medicine, RWTH Aachen University Hospital, Pauwelstraße 30, 52074 Aachen, Germany., Lobbes MBI; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.; Department of Medical Imaging, Zuyderland Medical Centre, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, The Netherlands., Smidt ML; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2023 Jan 07; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 07.

Value of ¹⁸ F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype.

Autor: de Mooij CM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands. c.demooij@maastrichtuniversity.nl.; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. c.demooij@maastrichtuniversity.nl.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands. c.demooij@maastrichtuniversity.nl., Mitea C; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands., Mottaghy FM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.; Department of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany., Smidt ML; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands., van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.

Publikováno v: EJNMMI research [EJNMMI Res] 2021 Nov 22; Vol. 11 (1), pp. 116. Date of Electronic Publication: 2021 Nov 22.